Ana Maria
Treviño Rodriguez–Casanova
Hospital General Universitario de Alicante
Alicante, EspañaPublicacións en colaboración con investigadores/as de Hospital General Universitario de Alicante (12)
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain
Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548
-
Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain
Journal of Clinical Virology, Vol. 167
-
Susceptibility to hepatitis B virus infection in adults living in Spain
Liver International, Vol. 43, Núm. 5, pp. 1015-1020
-
Treatment of hepatitis delta and HIV infection
Liver International, Vol. 43, Núm. S1, pp. 108-115
2022
-
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network
International Journal of Infectious Diseases, Vol. 122, pp. 970-975
-
Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain
Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169
2019
-
HTLV-1 infection in solid organ transplant donors and recipients in Spain
BMC Infectious Diseases, Vol. 19, Núm. 1
2017
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-Lymphotropic Virus Infection in Hepatitis C Virus-Antibody Positive Patients in Spain
AIDS Research and Human Retroviruses, Vol. 33, Núm. 10, pp. 1013-1017
2015
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2013
-
Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1
Journal of Neurology, Vol. 260, Núm. 10, pp. 2551-2555